Solarvest Bio Net debt/EBITDA
Was ist das Net debt/EBITDA von Solarvest Bio?
Net debt/EBITDA von Solarvest BioEnergy, Inc. ist -15.31
Was ist die Definition von Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA von Unternehmen in Industrials Sektor auf TSXV im Vergleich zu Solarvest Bio
Was macht Solarvest Bio?
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally. The company provides human nutrition products, including omega-3; and pharmaceutical ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. It has a collaborative research and development agreement with FSD Pharma Inc. to develop algae-based pharmaceutical grade cannabinoids. The company was incorporated in 2005 and is based in Vancouver, Canada.
Unternehmen mit net debt/ebitda ähnlich Solarvest Bio
- Leveljump Healthcare hat Net debt/EBITDA von -15.38
- Mineral Mountain Mining & Milling Co hat Net debt/EBITDA von -15.37
- Century Sage Scientific hat Net debt/EBITDA von -15.35
- iAnthus Capital hat Net debt/EBITDA von -15.34
- China Apex hat Net debt/EBITDA von -15.34
- VIQ Solutions hat Net debt/EBITDA von -15.32
- Solarvest Bio hat Net debt/EBITDA von -15.31
- IPE hat Net debt/EBITDA von -15.30
- EnerDynamic Hybrid Technologies hat Net debt/EBITDA von -15.24
- Meta Growth hat Net debt/EBITDA von -15.23
- Powerlong Commercial Management hat Net debt/EBITDA von -15.23
- Chinese People hat Net debt/EBITDA von -15.20
- PacRay International hat Net debt/EBITDA von -15.19